Standard
Reply to Roemer and Guermazi : Early biochemical changes on MRI can predict risk of symptomatic progression. / Kundu, Shinjini; Ashinsky, Beth G; Bouhrara, Mustapha; Dam, Erik B; Demehri, Shadpour; Shifat-E-Rabbi, M; Spencer, Richard G; Urish, Kenneth L; Rohde, Gustavo K.
I:
Proceedings of the National Academy of Sciences of the United States of America, Bind 118, Nr. 11, e2024679118, 2021.
Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt
Harvard
Kundu, S, Ashinsky, BG, Bouhrara, M
, Dam, EB, Demehri, S, Shifat-E-Rabbi, M, Spencer, RG, Urish, KL & Rohde, GK 2021, '
Reply to Roemer and Guermazi: Early biochemical changes on MRI can predict risk of symptomatic progression',
Proceedings of the National Academy of Sciences of the United States of America, bind 118, nr. 11, e2024679118.
https://doi.org/10.1073/pnas.2024679118APA
Kundu, S., Ashinsky, B. G., Bouhrara, M.
, Dam, E. B., Demehri, S., Shifat-E-Rabbi, M., Spencer, R. G., Urish, K. L., & Rohde, G. K. (2021).
Reply to Roemer and Guermazi: Early biochemical changes on MRI can predict risk of symptomatic progression.
Proceedings of the National Academy of Sciences of the United States of America,
118(11), [e2024679118].
https://doi.org/10.1073/pnas.2024679118Vancouver
Kundu S, Ashinsky BG, Bouhrara M
, Dam EB, Demehri S, Shifat-E-Rabbi M o.a.
Reply to Roemer and Guermazi: Early biochemical changes on MRI can predict risk of symptomatic progression.
Proceedings of the National Academy of Sciences of the United States of America. 2021;118(11). e2024679118.
https://doi.org/10.1073/pnas.2024679118Author
Kundu, Shinjini ; Ashinsky, Beth G ; Bouhrara, Mustapha ; Dam, Erik B ; Demehri, Shadpour ; Shifat-E-Rabbi, M ; Spencer, Richard G ; Urish, Kenneth L ; Rohde, Gustavo K. / Reply to Roemer and Guermazi : Early biochemical changes on MRI can predict risk of symptomatic progression. I: Proceedings of the National Academy of Sciences of the United States of America. 2021 ; Bind 118, Nr. 11.
Bibtex
@article{ea6b2099a266448083817deb30ac4d79,
title = "Reply to Roemer and Guermazi: Early biochemical changes on MRI can predict risk of symptomatic progression",
author = "Shinjini Kundu and Ashinsky, {Beth G} and Mustapha Bouhrara and Dam, {Erik B} and Shadpour Demehri and M Shifat-E-Rabbi and Spencer, {Richard G} and Urish, {Kenneth L} and Rohde, {Gustavo K}",
year = "2021",
doi = "10.1073/pnas.2024679118",
language = "English",
volume = "118",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
publisher = "The National Academy of Sciences of the United States of America",
number = "11",
}
RIS
TY - JOUR
T1 - Reply to Roemer and Guermazi
T2 - Early biochemical changes on MRI can predict risk of symptomatic progression
AU - Kundu, Shinjini
AU - Ashinsky, Beth G
AU - Bouhrara, Mustapha
AU - Dam, Erik B
AU - Demehri, Shadpour
AU - Shifat-E-Rabbi, M
AU - Spencer, Richard G
AU - Urish, Kenneth L
AU - Rohde, Gustavo K
PY - 2021
Y1 - 2021
U2 - 10.1073/pnas.2024679118
DO - 10.1073/pnas.2024679118
M3 - Letter
C2 - 33836609
VL - 118
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
SN - 0027-8424
IS - 11
M1 - e2024679118
ER -
